Blood Donors on Medication – an Approach to Minimize Drug Burden for Recipients of Blood Products and to Limit Deferral of Donors
Open Access
- 13 March 2009
- journal article
- research article
- Published by S. Karger AG in Transfusion Medicine and Hemotherapy
- Vol. 36 (2) , 107-113
Abstract
Background: Blood products derived from donors on medication can contain drugs which might pose a risk for the recipients or influence the quality of the product itself. Material and Methods: To judge the eligibility of blood donors on medication, 4 drug classes have been formed with respect to their pharmacological properties, and blood products have been divided in accordance with their single-donor plasma contents. Results: For drugs with dose-dependent pharmacodynamics, no deferral periods are necessary for donation of blood products containing less than 50 ml single-donor plasma for application to adults. Waiting periods of tmax + 5 t1/2 were calculated for the other blood products. Teratogenic drugs do not require special considerations (exception: retinoids, thalidomide and lenalidomide, dutasteride or finasteride with waiting periods for all blood products). A deferral period of tmax + 24 t1/2 is proposed for every blood product from blood donors on genotoxic drugs. Drugs without systemic effects can be neglected. Irreversible inhibitors of platelet function cause a 10-day waiting period if production of platelet concentrates is intended. Conclusion: Donors on medication are allowed to donate blood for blood products containing less than 50 ml plasma of a single donor, like red blood cell concentrates, for the use in adults without deferral periods, except those taking retinoids, thalidomide, lenalidomide, dutasteride, finasteride, or genotoxic drugs.Keywords
This publication has 17 references indexed in Scilit:
- Arzneimittelwirkungen – Lehrbuch der Pharmakologie und ToxikologieEndo-Praxis, 2008
- Selective Serotonin Reuptake Inhibitors and Risk of Upper GI Bleeding: Confusion or Confounding?The American Journal of Medicine, 2006
- Exposure to potential drug interactions in primary health careScandinavian Journal of Primary Health Care, 2003
- Blood donors on medicationEuropean Journal of Clinical Pharmacology, 2001
- Determination of plasma volume by indocyanine green – validation of the method and use in patients after cardiopulmonary bypassIntensive Care Medicine, 2001
- DRUGS IN DONATED BLOODThe Lancet, 1989
- Drugs in blood donors.Clinical Chemistry, 1987
- Incidence of Acetaminophen in Donated BloodVox Sanguinis, 1982
- Causes of Disqualification in a Volunteer Blood Donor PopulationTransfusion, 1977
- Plasmavolumen und extracelluläres Gewebswasser im Laufe der Entwicklung des KindesEuropean Journal of Pediatrics, 1954